iiinova — where your digital self keeps evolving

Reposted by Walter Stadler, MD

American Society of Clinical Oncology @ascocancer.bsky.social · 24/09/2026

On this #WorldCancerResearchDay, apply for the @conquercancer.bsky.social Career Development Award (CDA) to secure mentored clinical oncology funding. Open to US & international initial faculty. Apply by Oct 8: bit.ly/4iK0tWc #ResearchConquersCancer

001

Reposted by Walter Stadler, MD

American Society of Clinical Oncology @ascocancer.bsky.social · 13/08/2026

Applications are open for the @conquercancer.bsky.social International Innovation Grant (IIG)! 🧠 This grant supports oncology researchers residing in LMICs who are driving innovative, locally-focused cancer control projects. Submit your Letter of Intent by August 27, 2026: bit.ly/4hrQ150

001

Walter Stadler, MD @wmstadler.bsky.social · 18/06/2026

Way too frequently. Only slightly worse than genuflecting at p<0.05 as the breakpoint for “positive” vs “negative”

000

Walter Stadler, MD @wmstadler.bsky.social · 30/04/2026

PSM is incredibly difficult to define & there are other benefits to not developing advanced prostate cancer (e.g. avoiding androgen ablation). As such mortality statistics for screening any disease with decades long natural history are a, but not the only metric we should follow.

110

Reposted by Walter Stadler, MD

American Society of Clinical Oncology @ascocancer.bsky.social · 11/03/2026

We've updated Patient-Clinician Communication guidelines. New recommendations cover: 💬 Core communication skills 🔎 Prognosis & treatment selection 🫶 End-of-life care 🥼 Clinician training Improving the dialogue for better cancer care. Read the update: bit.ly/3NnMnMR

024

Walter Stadler, MD @wmstadler.bsky.social · 04/03/2026

You mean AI doesn’t solve the garbage in garbage out problem?

100

Reposted by Walter Stadler, MD

American Society of Clinical Oncology @ascocancer.bsky.social · 18/11/2025

In 1991, US cancer death rates hit an all-time high. Advances in early detection & treatment helped bring mortality rates down, averting 4.5 million deaths. Tell your lawmakers to support cancer research funding: brnw.ch/21wXB3j #SaveResearchStopCancer #ASCOAdvocacy

021

Reposted by Walter Stadler, MD

American Society of Clinical Oncology @ascocancer.bsky.social · 05/09/2025

Investing in research today prevents suffering tomorrow & ensures our national scientific standing. We cannot turn away from millions counting on American ingenuity to live healthier lives. #ASCOAdvocacy #SaveResearchStopCancer Take action with us: brnw.ch/21wVvP3

062

Reposted by Walter Stadler, MD

Dan Rather @thedanrather.bsky.social · 30/08/2025

The acting head of the CDC is a tech bro with no medical training who embraced Covid conspiracy theories. Talk about malpractice.

steady.substack.com

A Dangerous Liaison

Trump and RFK Jr. play politics with public health and safety

16557193

Reposted by Walter Stadler, MD

American Society of Clinical Oncology @ascocancer.bsky.social · 28/08/2025

50 years ago, surviving cancer was a rarity. Federally funded research changed that for millions of Americans. But progress is now at risk. Unstable funding threatens to halt future breakthroughs #SaveResearchStopCancer #ASCOAdvocacy Take action with us: brnw.ch/21wVh17

123

Reposted by Walter Stadler, MD

Union of Concerned Scientists @ucs.org · 14/08/2025

Calling all scientists and science supporters! You have a crucial role to play in countering the authoritarian threat we currently face in this country. Learn more about how you can stand up for the facts and truth that are essential for a free and democratic society. blog.ucs.org/gretchen-gol...

15167552579

Reposted by Walter Stadler, MD

PBS News @pbsnews.org · 22/07/2025

PBS News is not going anywhere. We will continue our work without fear or favor, as we have for nearly five decades on the air. We are profoundly grateful to Viewers Like You for your loyalty and unwavering support.

738352058705

Reposted by Walter Stadler, MD

American Society of Clinical Oncology @ascocancer.bsky.social · 07/07/2025

Join us at Best of ASCO Minneapolis, July 11-12, for the cutting-edge research selected by experts in your field, and while you’re there take advantage of some of the best the city has to offer! Don't forget to register: brnw.ch/21wTX02

011

Reposted by Walter Stadler, MD

Andrew Vickers @vickersbiostats.bsky.social · 24/06/2025

"Patients with grade group (GG) 1 on biopsy can have higher grade disease on surgery. So GG1 = cancer". But also true of benign: "Patients with benign on biopsy can have higher grade disease on surgery"

001

Reposted by Walter Stadler, MD

Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 10/05/2025

🇺🇸Take @ascocancer.bsky.social action today: 1️⃣ The proposed federal budget requires significant reductions in spending 2️⃣ >70M rely on Medicaid for healthcare, including millions of Americans with cancer 3️⃣ Write Congress & demand Medicaid be protected It's easy! asco.quorum.us/campaign/115...

asco.quorum.us

Medicaid

Urge Congress to Protect Cancer Patients on Medicaid

076

Reposted by Walter Stadler, MD

American Society of Clinical Oncology @ascocancer.bsky.social · 02/05/2025

ASCO is calling on lawmakers to uphold the U.S.’s role as a global leader in scientific and medical innovation and preserve vital federal cancer prevention and research funding. #ASCOAdvocacy Read our statement: shorturl.at/kZwjr

0136

Walter Stadler, MD @wmstadler.bsky.social · 02/04/2025

This needs to be amplified. The unfortunate increase in cancers in young individuals, especially for colorectal cancer, has created a public narrative that cancer rates are increasing

031

Reposted by Walter Stadler, MD

ANZUP Cancer Trials Group @anzuptrials.bsky.social · 31/03/2025

April is Testicular Cancer Awareness Month – a time to recognise the prevalence of this Below the Belt cancer and the incredible people working to improve outcomes. Their dedication is driving better treatments, improving patient care, and bringing hope to those affected.💙👏

033

Walter Stadler, MD @wmstadler.bsky.social · 29/03/2025

It’s a travesty, but how do we respond? Is this a scenario where we argue there’s an individual need for each of these cancers or can we speak with one voice that cancer research is critical? In my view there’s a “divide & conquer” approach here.

110

Reposted by Walter Stadler, MD

Katie Coleman @katiekickscancer.bsky.social · 09/03/2025

Cancer research needs us right now @kidneycan.bsky.social

064

Walter Stadler, MD @wmstadler.bsky.social · 09/03/2025

Katie provides the moral imperative far more eloquently than I can. For those who require an economic argument, the US research enterprise is the most robust in the world creating $100B in wealth. It is one of our most successful exports.

031

Reposted by Walter Stadler, MD

Julie Gralow @jrgralow.bsky.social · 24/02/2025

.@ascocancer.bsky.social engages in judicial and legislative advocacy to protect NIH funding: www.asco.org/news-initiat...

asco.org

ASCO Engages in Judicial and Legislative Advocacy to Protect NIH Funding - ASCO

074

Reposted by Walter Stadler, MD

Holden Thorp @holdenthorp.bsky.social · 24/02/2025

The response of the science community to the last month is not about one statement or action. It's about all of us with our different frames. For Science's part, we are doing what we have always done and have no plans to change. My thoughts on what we can do. www.science.org/doi/10.1126/...

science.org

Come together, right now

The chaos, conflicting information, firings, and hurtful rhetoric of the Trump administration’s approach to science over the past month are causing anxiety, grief, and concern for the scientific commu...

6264116

Reposted by Walter Stadler, MD

American Society of Clinical Oncology @ascocancer.bsky.social · 21/02/2025

We are committed to advancing policies that improve patient access to high-quality cancer care. We continue to collaborate with all stakeholders to address existing barriers and ultimately improve cancer care for those in need.

healio.com

‘Lose-lose-lose’ scenario: ASCO seeks reduced out-of-pocket costs for cancer care

Out-of-pocket costs like deductibles and copays deter people with cancer from complying with treatment.This creates a “lose-lose-lose” scenario for patients, payers and employers, Clifford...

074

Walter Stadler, MD @wmstadler.bsky.social · 02/02/2025

With this logic pts who are heavy smokers should be labeled as “group 1 lung cancer” because of their high risk for clinically significant lung cancer.

100

Reposted by Walter Stadler, MD

American Society of Clinical Oncology @ascocancer.bsky.social · 24/01/2025

We applaud new draft guidance from the @fda.gov & OHRP on incl tissue biopsies in clinical trials. In The Cancer Letter editorial, we stated guidance closely aligns w our ongoing efforts to improve ethics of research biopsies, esp biopsies that are mandatory. More: brnw.ch/21wQetz

brnw.ch

ASCO Applauds New Draft Guidance on Including Tissue Biopsies in Clinical Trials

ASCO welcomes new draft guidance on including tissue biopsies in clinical trials.

071